Fenoldopam Mesylate Enhances the Survival of Mesenchymal Stem Cells Under Oxidative Stress and Increases the Therapeutic Function in Acute Kidney Injury
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fenoldopam Mesylate Enhances the Survival of Mesenchymal Stem Cells Under Oxidative Stress and Increases the Therapeutic Function in Acute Kidney Injury
Authors
Keywords
-
Journal
CELL TRANSPLANTATION
Volume 32, Issue -, Pages 096368972211479
Publisher
SAGE Publications
Online
2023-01-03
DOI
10.1177/09636897221147920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications
- (2021) Alejandro Olivares-Hernández et al. Biomolecules
- Improved therapeutics of modified mesenchymal stem cells: an update
- (2020) Dickson Kofi Wiredu Ocansey et al. Journal of Translational Medicine
- Stem cell-based treatment of kidney diseases
- (2020) Binbin Pan et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Quercetin Attenuates Pancreatic and Renal D-Galactose-Induced Aging-Related Oxidative Alterations in Rats
- (2020) Ali H. El-Far et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury
- (2020) Song Zhou et al. Cell and Bioscience
- Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
- (2019) Guido Moll et al. TRENDS IN MOLECULAR MEDICINE
- Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease
- (2019) Chul Yun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Acute kidney injury overview: From basic findings to new prevention and therapy strategies
- (2019) Sabrina Ribeiro Gonsalez et al. PHARMACOLOGY & THERAPEUTICS
- Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
- (2019) Henry Caplan et al. Frontiers in Immunology
- Preventing acute kidney injury and improving outcome in critically ill patients utilizing risk prediction score (PRAIOC-RISKS) study. A prospective controlled trial of AKI prevention
- (2019) Tarek Samy Abdelaziz et al. JOURNAL OF NEPHROLOGY
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
- (2018) Jacques Galipeau et al. Cell Stem Cell
- Preconditioning influences mesenchymal stem cell properties in vitro and in vivo
- (2018) Chenxia Hu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application
- (2018) Mengyuan Wang et al. Stem Cells International
- Hypoxic Preconditioning Promotes the Bioactivities of Mesenchymal Stem Cells via the HIF-1α-GRP78-Akt Axis
- (2017) Jun Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
- (2016) Agnieszka Loboda et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hypoxic preconditioning enhances mesenchymal stromal cell lung repair capacity
- (2015) Fernanda Ferreira Cruz et al. Stem Cell Research & Therapy
- In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments
- (2014) Fatemeh Amiri et al. CELL STRESS & CHAPERONES
- Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury
- (2014) Hong-Hwa Chen et al. JOURNAL OF PINEAL RESEARCH
- World Incidence of AKI: A Meta-Analysis
- (2013) P. Susantitaphong et al. Clinical Journal of the American Society of Nephrology
- Renal Dopamine Receptors, Oxidative Stress, and Hypertension
- (2013) Santiago Cuevas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Key Regulatory Roles of the PI3K/Akt Signaling Pathway in the Functionalities of Mesenchymal Stem Cells and Applications in Tissue Regeneration
- (2013) Jiezhong Chen et al. TISSUE ENGINEERING PART B-REVIEWS
- Autologous cell therapy for cisplatin-induced acute kidney injury by using non-expanded adipose tissue-derived cells
- (2012) Kaoru Yasuda et al. CYTOTHERAPY
- Reactive Oxygen Species in Health and Disease
- (2012) Assim A. Alfadda et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Mitochondrial ROS Generation and Its Regulation: Mechanisms Involved in H2O2 Signaling
- (2010) Michel Rigoulet et al. ANTIOXIDANTS & REDOX SIGNALING
- Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase
- (2010) I. Stroo et al. INTERNATIONAL IMMUNOLOGY
- Mediators of Inflammation in Acute Kidney Injury
- (2010) Ali Akcay et al. MEDIATORS OF INFLAMMATION
- Pharmacology of signaling induced by dopamine D1-like receptor activation
- (2010) Ashiwel S. Undieh PHARMACOLOGY & THERAPEUTICS
- Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
- (2010) Soufiane Ghannam et al. Stem Cell Research & Therapy
- D 1 -Like Receptors Regulate NADPH Oxidase Activity and Subunit Expression in Lipid Raft Microdomains of Renal Proximal Tubule Cells
- (2009) Hewang Li et al. HYPERTENSION
- Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury
- (2008) S. S. Waikar et al. Clinical Journal of the American Society of Nephrology
- Genistein protects the kidney from cisplatin-induced injury
- (2008) Mi Jeong Sung et al. KIDNEY INTERNATIONAL
- Neuroprotective effects of atypical D1receptor agonist SKF83959 are mediated via D1receptor-dependent inhibition of glycogen synthase kinase-3β and a receptor-independent anti-oxidative action
- (2007) Yang Yu et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started